Role of Acetylcholinesterase (AChE) reactivators in the treatment of Organophosphorus poisoning: in vivo, in vitro, and in silico studies

Role of Acetylcholinesterase (AChE) reactivators in the treatment of Organophosphorus poisoning: in vivo, in vitro, and in silico studies

Chemical warfare agents, especially organophosphorus (OP) compounds, are known for their extreme toxicity causing inhibition of acetylcholinesterase (AChE) enzyme activity due to covalent phosphorylation. This leads to functional impairment of muscarinic nicotinic acetylcholine receptors, resulting in severe ill effects that ultimately lead to death. For OP poisoning, AChE reactivators play a crucial role in the treatment process. Among several AChE reactivators, Oxime reactivators are majorly employed for the treatment of OP intoxication, nevertheless, these are associated with certain drawbacks such as their toxic effects, low blood-brain barrier (BBB) penetration, less reactivation in the central nervous system (CNS), and inefficiency toward all nerve agents, and blocked AChE. As a result, new therapeutic strategies are required. Recent attempts are focused on the design and synthesis of uncharged oximes or non-oxime reactivators which can overcome the limitations of oxime-based reactivators. A novel class of non-oxime reactivators is gaining interest, including compounds like Mannich phenols, chloroquines, and some general bases. This review is a novel attempt to incorporate various possible oxime and non-oxime AChE reactivators for OP intoxication along with their in vitro, in vivo, and in silico studies.

URN:NBN:sciencein.cbl.2023.v10.538

Role of Acetylcholinesterase (AChE) reactivators in the treatment of Organophosphorus poisoning: in vivo, in vitro, and in silico studies – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/538

Chemical Biology Letters

In-vitro evaluation of synergism in antioxidant efficiency of Quercetin and Resveratrol

In-vitro evaluation of synergism in antioxidant efficiency of Quercetin and Resveratrol

Plants serve as an excellent source of therapeutic molecules that help in medicinal treatments. The production of large amounts of pure phytocompounds from plant sources for human consumption and the nature of phytocompounds exhibiting toxicity issues at higher dosages lead to the challenge of increasing the therapeutic effect by using low dosages. This current study focuses on extracting two active antioxidant compounds, quercetin (Q) and resveratrol (R), from plant sources and evaluating their ability to exhibit antioxidant synergism through in vitro models. Quercetin and resveratrol were extracted using an ethanol-solvent extraction procedure from Allium cepa, and Vitis vinifera peels, respectively. The extracts were subjected to qualitative and quantitative analysis, column chromatography and then High-Performance Liquid chromatography for purification. DPPH, ABTS+, SOS, and cellular antioxidant assays evaluated the synergistic antioxidant activity of the quercetin and resveratrol complex. The results showed synergistic antioxidant efficacy values approximately as follows: 5.37 % in DPPH, 15.26 % in ABTS+, 11.99 % in SOS, and 19.13 % in cellular antioxidant assays when both molecules were used combinedly. The results promisingly pave the way for a new dimension in nutraceuticals formulation parameters which could trigger combined molecular usage to achieve better results at low dosages.

URN:NBN:sciencein.cbl.2023.v10.534

In-vitro evaluation of synergism in antioxidant efficiency of Quercetin and Resveratrol – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/534

Chemical Biology Letters

Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis

Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis

Targeting of epidermal growth factor receptors (EGFRs) and vascular endothelial growth factor receptors (VEGFRs) has become a major strategy for the control of head and neck cancer. c-MET, a receptor tyrosine kinase is known to be expressed in many cancers including the head and neck squamous cell carcinoma (HNSCC). The c-MET activity has been correlated with many signaling pathways that help the cancer cells to proliferate, migrate and invade into the normal, healthy tissues. The association of c-MET with glycolytic pathway in HNSCC has not been elucidated yet. Since, increased glycolysis has emerged as a major hallmark for cancer cell proliferation, targeting c-MET could bring an impact to inhibit HNSCC progression. In the present study we use various In-silico tools available to identify the association of c-MET with the major metabolic genes such as HK-II (Hexokinase-II), GLUT-1 (Glucose transporter-I), LDH-A (Lactate dehydrogenase-A), PFK-II (Phosphofructokinase-II) and MCT-1 (Monocarboxylate transferase-1) in HNSCC patient datasets available from The Cancer Genome Atlas (TCGA). Protein networking analysis was used to determine the correlation of c-MET with the metabolic genes. Retrieved sequenced data pathway analysis gives the network of genes associated in the activation of glycolytic pathway. Gene ontology and Enrichr studies provide an insight into c-MET activity in metabolism through molecular, functional and pathway basis in HNSCC. Furthermore, we also have shown a negative correlation of c-MET with immune cell infiltration, suggesting c-MET might have a role in immune suppression in HNSCC patients. Further validation on this study could possibly make c-MET as a potential target to inhibit HNSCC.

URN:NBN:sciencein.cbl.2023.v10.532

Deciphering the role of c-MET in Metabolic reprogramming of Head and Neck squamous cell Carcinoma via In Silico analysis – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/532

Chemical Biology Letters

New Drug Delivery Review Article 2022, 2023

The drug delivery is an important factor now in rationalization of any new or existing drug towards specific ailment, the most prominently against the cancer where drug delivery systems have been extensively explored. The new advancement in drug delivery using different nano-particular systems viz. metal nanoparticles, liposomes, dendrimers, lipids, carbon nanomaterials, niosomes, phytosomes, virus, and other systems are moving towards the precision drug delivery.

All different aspects towards a precise drug delivery have been discussed in a recent review article that has been published in the ‘Applied NanoMedicine’. Readers can access the article PDF at:

The above article should also serve your queries related to drug delivery article 2023; drug delivery article 2022; new drug delivery systems; precise drug delivery; gene delivery article 2022; recent advances in drug delivery; advanced drug delivery reviews; journal article; drug delivery review PDF; Drug delivery systems updated review – PMC – NCBI; commercial drug delivery technologies; current research in drug delivery; precision nanoparticles for drug delivery – Nature; drug delivery review article; new drug delivery methods; drug delivery system pdf; drug delivery systems examples; importance of drug delivery system; Novel drug delivery system review article and related queries.

Authors can publish similar articles related to drug delivery research in the journal ‘Applied Nanomedicine‘ , the submission details, template and journal information is provided on the link

https://pubs.thesciencein.org/journal/index.php/nanomed

Regioselective synthesis of indole-thiazolidine-2,4-dione coupled isoxazoles as in vitro tubulin polymerization inhibitors

Regioselective synthesis of indole-thiazolidine-2,4-dione coupled isoxazoles as in vitro tubulin polymerization inhibitors

Herein we synthesized new indole-thiazolidine-2,4-dione coupled isoxazoles (7a-n) via simple reactions like N-propargylation, Knoevenagel condensation and copper (I) catalysed one pot regioselective reactions. All the newly synthesized compounds were characterized by 1H-NMR, 13C-NMR and Mass spectra and they were screened for in vitro anticancer activity against three human cancer cell lines like A549 (lung), MCF-7 (breast), and SKOV3 (ovarian) using MTT assay and etoposide was used as the standard drug. As per the results the compounds 7e, 7f and 7g where shown selectivity towards A549 cell line with IC50 values of 5.27 µM, 3.14 µM and 6.25 µM respectively and they are high active than etoposide. Further in vitro tubulin polymerization assay on three potent compounds (7e, 7f and 7g) revealed that compounds 7e and 7f have exhibited potency than standard combretastatin A-4 with IC50 values 0.82 and .044 mM respectively.

URN:NBN:sciencein.cbl.2023.v10.531

Regioselective synthesis of indole-thiazolidine-2,4-dione coupled isoxazoles as in vitro tubulin polymerization inhibitors – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/531

Chemical Biology Letters

In Silico Docking Studies of Yucca gloriosa L. Phytoconstituents with TNF-α, IL-6 and IL-13 Receptor Against Asthma

In Silico Docking Studies of Yucca gloriosa L. Phytoconstituents with TNF-α, IL-6 and IL-13 Receptor Against Asthma

Yucca gloriosa L. has been comprehensively assessed in vitro and in vivo for its action against asthma. Y. gloriosa L. is a rich source of phenolic compounds such as gloriosaols A-E and yuccaols A-E, which exhibit potent antioxidant activity. Gloriosaols A-E and yuccaols A-E are structurally related to corticosteroids. The current study describes the in silico docking of some important anti-asthmatic phytoconstituents from the plant Y. gloriosa L. with molecular targets of asthma. Toward the recognition of the binding methods of these pharmacologically dynamic components, molecular modelling studies were carried out with target proteins, i.e., interleukin (IL)-6 (1N26), IL-13 (3LB6) and TNF-α (2AZ5), using in silico molecular docking. The components demonstrated encouraging binding interactions with the amino acid residues at the active sites of these proteins, authenticating their verified efficiency as anti-asthmatic agents. The current research, in addition, provides insight into the possible herbal drug-receptor interaction and synthetic drug montelukast sodium receptor interaction, for the possible management of asthma.

URN:NBN:sciencein.cbl.2023.v10.509

In Silico Docking Studies of Yucca gloriosa L. Phytoconstituents with TNF-α, IL-6 and IL-13 Receptor Against Asthma – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/509

Chemical Biology Letters

Nanoemulsion of Mentha piperita essential oil active against Mycobacterium strains

Nanoemulsion of Mentha piperita essential oil active against Mycobacterium strains

Present investigation aimed to study the antimycobacterial potential of Mentha piperita essential oil fractions, identify its active constituents by GC-MS and preparation of nanoemulsion from biologically active fraction. Four oil fractions (R1, R2, R3, R4) were collected during hydrodistillation of Mentha piperiata leaves and tested in the two of mycobacterial strains by conventional disc diffusion method. Oil fractions R2 and R3 demonstrated maximum zone of inhibition of 39 mm and 36 mm in Mycobacterium smegmatis, 33 mm and 31 mm in Mycobacterium bovis BCG respectively at a dilution of 75% in DMSO compared to standard drug isoniazid (23 mm in 4 µg/ml). GC-MS analysis of the most active fraction R2 reveals the presence of menthol (70.69%), isomenthone (14.63%) and neomenthol (6.82%) as major constituents. To enhance bioavailability of oil fraction, the nanoemulsions were prepared from R2 by sonication method. Nanoemulsions, N1 and N2 prepared by varying surfactant concentrations were tested in Mycobacterium bovis BCG using quantitative and colorimetric resazurin microtiter assay (REMA). Nanoemulsions, N1 and N2 have shown 97-100 % bacterial growth inhibition at 3.125 % concentration in the culture medium compared with the culture control.

URN:NBN:sciencein.cbl.2023.v10.507

Nanoemulsion of Mentha piperita essential oil active against Mycobacterium strains – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/507

Chemical Biology Letters

Development and validation of Hand-held device for the rapid detection of Metformin in biological samples: A forensic application

Development and validation of Hand-held device for the rapid detection of Metformin in biological samples: A forensic application

Metformin is a widely used anti-diabetic drug that enhances glycaemic control by advancing the insulin sensitivity abatement of intestinal glucose absorption. Due to its versatility, it is also emerging as an abused drug leading to toxicity and fatal conditions. Detection of metformin with the existing qualitative and quantitative approaches necessitate complex and intricate instrumentation, fully facilitated laboratories, and trained scientist and technicians. Henceforth, in the current study, we have developed a hand-held electronic device-based detection system for metformin using the basic principles of spectrophotometry. It is based on the formation of a yellowish-green color complex (wavelength 680nm) which involves the oxidative coupling of 3-methyl 2-benzothiozoline hydrazone (MBTH) catalyzed by iron. The method developed has been optimized at different pH, reaction temperature, and reaction time and found to be specific, sensitive, and linear in the range of concentration 100-1000 µg/ml with the limit of detection (LOD) of 120.5 µg/ml.

URN:NBN:sciencein.cbl.2023.v10.486

Development and validation of Hand-held device for the rapid detection of Metformin in biological samples: A forensic application – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/486

Chemical Biology Letters

cancer statistics in India 2022

India’s cancer statistics are recorded by the National Cancer Registry Programme (NCRP) of the National Center for Disease Informatics and Research (NCDIR), Bengaluru, an institute of the Indian Council of Medical Research (ICMR). The ICMR-NCDIR-NCRP pulls the data through 36 PBCRs (Population-based cancer registry) and 236 HBCRs (Hospital-based cancer registry). The approximate projected cases of cancer in India were 1,392,179 (~1.4 million) in the year 2020, leading to 850,000 (~0.85 million) deaths due to cancers. The five leading cancers in India, as per reported data, were breast, lung, mouth, cervix uteri, and tongue. The sex-based incidences reported were 679,421 male patients and 712,758 female patients. Breast and cervix uteri cancers were the most common cancer types in females in India. Breast cancer incidences show steady increasing reporting trends, and the majority of incidences reported are from metropolitan cities. The increasing reports of breast cancer in women pose a concern for health agencies for necessary action to control and generate necessary medical facilities. Lung, mouth, esophagus, stomach, and nasopharynx cancer are prominent in males. Lung cancer, the leading type of cancer reported in metropolitan cities, is in general agreement with the trend line of global data. The presumptive association of lung cancer with tobacco smoking and prevalent air pollution in cities is consistent with this trend. The increasing use of synthetic pesticides in agriculture has also been considered a contributing factor along with improper industrial waste disposal practices for increasing cancer cases, particularly associated with the prevalence of new cases of cancer in specific regions. The PCBRs data indicated the association of almost a third of cancer incidences with tobacco use (smoking and chewing) in India. The social norms related to avoiding tobacco use have been emphasized towards preventive measures for most cancer cases in India.

Excerpt from the article below:

Read Full article at https://pubs.thesciencein.org/journal/index.php/cbl/article/view/451

Global Cancer Statistics 2022: the trends projection analysis

Published in Chemical Biology Letters


Also refer above article link for queries: Cancer prevalence 2022; Cancer incidences in India; Cancer prevalence in India 2022; Cancer statistics in India; report 2023; Cancer types in India; Role of pesticides in Cancer cases in India; Tobacco smoking and cancer in India; female cancer type in India; Male cancer types in India; Total case of cancer; worldwide cancer statistics 2022; world and India cancer cases and deaths; cancer deaths in India; lung cancer cases in India; breast cancer cases in India; leading cancer types in India; covid-19 and cancer; drugs for cancer; research advances in cancer;

Global Cancer Statistics 2022: the trends projection analysis

Global Cancer Statistics 2022: the trends projection analysis

Cancer is one of the most fatal diseases of recent times that causes several deaths every year. The disease variations in different parts of the world, the impact of available medical facilities, and other socio-economic factors have impacted the proper management of this disease. The comparative statistical data of cancer types like breast, prostate, colon, lung, lymph, blood, brain, and kidney cancers can be used to design treatment strategies and therapeutics development. With the advancement of science, several drugs besides diagnostic methods have emerged to control respective cancer and have assisted in curing this disease to some extent. The comparative statistics analysis for cancer about current prevalence is included here to bring a clear framework for the efforts towards future drug development to manage this disease. The availability of new diagnostics and therapeutics and advanced medical facilities in clinics impact cancer statistics. An evaluation of current trends and statistics of cancer pathology vis-à-vis theranostics (diagnostics as well as therapeutics) progress with possible application in clinical settings constitutes the core part of the discussion in this review.

URN:NBN:sciencein.cbl.2023.v10.451

Global Cancer Statistics 2022: the trends projection analysis – https://pubs.thesciencein.org/journal/index.php/cbl/article/view/451

Chemical Biology Letters